Pharmacy Medical News about rhinitis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: Effects on nasal congestion
Allergy and Asthma Proceedings, 06/30/09

Prenner B et al. - Nasal decongestant activity of L/M was significantly higher than that of placebo and similar to that of PSE in symptomatic AR subjects. L/M showed a safety profile similar to placebo and was better tolerated than PSE. Thus, L/M offers a safe and efficacious alternative to PSE for the treatment of nasal congestion associated with AR.

<< Previous
Long-term use of felbamate: Clinical outcomes and effect of age...

Next >>
High-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune...

Time Interval and the Factors Associated with the Development of Asthma in Patients with Allergic Rhinitis
Lung, 10/09/09 Relevance Score: 91%

Nonallergic Rhinitis Symptoms More Severe Than Allergic Rhinitis
ScienceDaily, 10/06/09 Relevance Score: 89%

Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis
Journal of Allergy and Clinical Immunology, 10/12/09 Relevance Score: 88%

Botox Sponge Replaces Needles for Rhinitis Patients
Ivanhoe, 10/19/09 Relevance Score: 87%

No Need For Needles: Botox Sponge Treats Intrinsic Rhinitis
ScienceDaily, 10/16/09 Relevance Score: 87%